Immunocompromised Patient
Immunocompromised Patient - Related Videos
05:10
Intracranial Orthotopic Allografting of Medulloblastoma Cells in Immunocompromised Mice
0 Views •
Cited by 5 •
2010
This protocol describes the isolation and dissociation of mouse medulloblastoma tissue, and subsequent allografting of the tumor cells into immunocompromised recipient mice in order to initiate secondary medulloblastoma.
03:40
Intrafemoral Injection of Human Hematopoietic Stem and Progenitor Cells into Immunocompromised Mice
0 Views •
2023
Intrafemoral injections allow for the engraftment of a small number of hematopoietic stem and progenitor cells (HSPCs), by placing the cells directly in the bone marrow cavity. Here we describe an experimental protocol of intrafemoral injection of human HSPCs into immunodeficient mice.
03:32
Patient-derived Tumor Xenografting: A Technique to Generate Experimental Mouse Model for Evaluating Urothelial Cell Carcinoma
0 Views •
2023
This video describes the procedure to generate an experimental xenograft murine model, which can be used for studying urothelial cell carcinoma progression.
08:03
Generation of Prostate Cancer Patient Derived Xenograft Models from Circulating Tumor Cells
0 Views •
Cited by 59 •
2015
This manuscript details a method used to generate prostate cancer patient derived xenografts (PDXs) from circulating tumor cells (CTCs). The generation of PDX models from CTCs provides an alternative experimental model to study prostate cancer; the most commonly diagnosed tumor and a frequent cause of death from cancer in men.
08:10
Proper Adjustment of Patient Attire during the Physical Exam
0 Views •
2023
Source: Jaideep S. Talwalkar, MD, and Joseph Donroe, MD, Internal Medicine and Pediatrics, Yale School of Medicine, New Haven, CT In order to optimize the predictive value of the physical examination, the provider must perform maneuvers correctly. The proper use of drapes is an important component of correctly performing physical examination maneuvers. Skin lesions are missed when "inspection" occurs through clothing, crackles are erroneously reported when the lungs are examined through a...
FAQs
The clinical consequences depend on which immune functions are weakened. Reduced neutrophil activity can limit early innate defense, while impaired antibody production or T-cell responses can weaken adaptive protection. Because these systems also coordinate inflammation, a patient may have both greater susceptibility to opportunistic infections and a less obvious inflammatory response, complicating early recognition.
Immune impairment may blunt the inflammatory signals that normally make infection apparent, so symptoms can be subtle rather than dramatic. At the same time, an infection may progress rapidly because host defenses are limited. This combination makes changes in condition clinically important and supports careful monitoring, prompt assessment, and early intervention when infection is suspected.
Reduced immune function can alter the response to vaccination, so immunocompromised patients may not develop protection in the same way as patients with intact defenses. Impaired immune surveillance can also affect recognition of abnormal cells. These effects make vaccination strategies and cancer surveillance important parts of medical planning, alongside evaluation of the underlying immune problem.
The source of immune impairment helps indicate which defenses may be affected and how medical risks should be considered. Underlying disease, genetic conditions, infection, chemotherapy, corticosteroids, and organ transplantation can create different clinical contexts. Identifying that context supports more appropriate risk assessment and helps clinicians tailor diagnostic testing, prevention, monitoring, and treatment decisions.
Before a procedure or therapy, clinicians should account for the patient’s reduced defenses, the underlying cause, and the possibility of rapid or subtly presenting infection. This assessment helps guide decisions about diagnostic testing, antimicrobial prophylaxis, vaccination strategies, and whether additional precautions or monitoring are needed. The goal is to reduce preventable complications while selecting appropriate care.
Diagnostic testing helps evaluate suspected infection when clinical signs may be limited or atypical. Antimicrobial prophylaxis may be considered as part of prevention for patients whose immune impairment creates increased risk, rather than waiting for infection to develop. Together with risk assessment and monitoring, these measures support earlier recognition and help reduce the consequences of opportunistic infection.
Vaccination planning should recognize that immune impairment can change the response to vaccines. Clinicians therefore incorporate the patient’s immune status, underlying condition, and treatment context into broader prevention decisions. Vaccination strategies work alongside antimicrobial prophylaxis, diagnostic evaluation, and monitoring; they are not a substitute for promptly assessing new or subtle signs of infection.
Monitoring is central because infections may advance quickly while producing only subtle clinical signs. Regular attention to changes in condition allows clinicians to pursue diagnostic testing and early treatment before complications become more severe. In medicine, monitoring also supports ongoing decisions about prophylaxis, vaccination strategies, procedures, and therapies as the patient’s immune status or treatment context changes.